Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound for preventing and treating bacterial infection and its prepn and use

A compound and bacterial technology, applied in the field of a class of compounds for treating or preventing bacterial infections and their preparation and use, can solve problems such as drug resistance

Inactive Publication Date: 2006-08-02
SHANGHAI DONGHAO MEDICINE BIOLOGY ENTERPRISE
View PDF9 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although this development method has achieved some success, the new variants usually show better efficacy than the old drugs, have a broader antibacterial spectrum, or can overcome some drug resistance mechanisms, but shortly after the market, microorganisms are resistant to various new drugs. resistance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound for preventing and treating bacterial infection and its prepn and use
  • Compound for preventing and treating bacterial infection and its prepn and use
  • Compound for preventing and treating bacterial infection and its prepn and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0098] Embodiment 1. the synthesis of novel antibacterial compound series

[0099]Infectious diseases are currently one of the main factors leading to the death of the world's population. According to the statistics of the World Health Organization in 2002, in the past 10 years, the number of deaths due to infectious diseases has exceeded a quarter of the world's annual death toll. There was once optimism that infectious diseases had been conquered because of the discovery of antibiotics. However, the ensuing problem of bacterial resistance has awakened human beings from their dreams. Half a century ago, most infections caused by Staphylococcus aureus were sensitive to penicillin. Today, such infections are not only resistant to penicillin, but also to many antibiotics developed later. In addition to hospital-acquired infections, the problem of bacterial resistance is threatening healthy populations. Diseases that were once manageable (such as gonorrhea, typhoid, and tuberc...

Embodiment 2

[0136] Example 2. Activity of Novel Antibacterial Compounds

[0137] The compounds EB-1 and EB-2 described here should be 4-(4-biphenyl)-4'-guanidinium methylbenzoate hydrochloride and 4-(4-aminobiphenyl) respectively -4'-guanidine methylbenzamide hydrochloride can specifically inhibit the growth of cocci. 8 synthetic compounds were tested against Staphylococcus aureus standard strain (ATCC25923), Sarcina luteus standard strain (ATCC9341), Staphylococcus epidermidis standard strain (ATCC12228), Pseudomonas aeruginosa standard strain (ATCC2785), Shigella standard strain (Shanghai Health and Epidemic Prevention Station 51573) and Escherichia coli standard strain (ATCC25922) the minimum inhibitory concentration (MIC, μg / ml), EB-1 and EB-2 against cocci MIC range from 1.25 to 10μg / ml. Compared with the broad-spectrum antibiotic ceftriaxone, the above compounds have no obvious inhibitory activity on rod-shaped bacteria (see Table 1).

[0138] Table 1

[0139] In order to know ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to compound for preventing and treating bacterial infection, especially diseases caused by methicillin resisting Staphylococcus aureus, methicillin resisting Staphylococcus epidermidis, Escherichia coli producing extremely-broad spectrum beta-lactamases, Klebsiella pneumoniae and fecal enterococcus producing inactivating enzyme, and its preparation process and medical use.

Description

technical field [0001] The present invention relates to the treatment or prevention of infection by certain bacteria, especially methicillin-resistant Staphylococcus aureus (MRSA), methicillin-resistant Staphylococcus epidermidis (MRSE), extended-spectrum beta-lactamases (ESBLs) ) of Escherichia coli and Klebsiella pneumoniae and inactivated enzyme-producing Enterococcus faecalis infection caused or accompanying diseases or symptoms, its preparation method and medical use. Background technique [0002] The 20th century was an era of rapid development of antibacterial drugs. In the 1930s, sulfa drugs were discovered, and penicillin was initially used in the 1940s. A large number of important antibiotics such as aminoglycosides, chloramphenicol, tetracyclines, and macrolides were developed immediately, followed by semi-synthetic penicillins, cephalosporins, and new β-lactams. The advent of antibacterial drugs such as quinolones and quinolones has made effective treatment of v...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C279/14A61K31/165A61P31/04A61P11/00A61P13/02A61P1/16A61P15/00A61P17/00A61P1/02
CPCY02A50/30
Inventor 王明伟谢建树朱德煦村松睦唐磊李伯俊
Owner SHANGHAI DONGHAO MEDICINE BIOLOGY ENTERPRISE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com